Alkyl Amines Chemicals Ltd (ALKYLAMINE) is currently trading at 1,634.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Alkyl Amines Chemicals Limited is a specialist chemicals manufacturer producing aliphatic amines, amine derivatives and specialty intermediates from three Indian plants (Patalganga, Kurkumbh and Dahej) with an R&D centre in Pune; its products serve pharma, agrochemical, water treatment and specialty industrial markets globally, supported by in-house hydrogen and downstream derivative capability. FY26 performance was essentially flat: management reported top line and bottom line roughly unchanged year‑on‑year within a plus/minus one percent band, with volumes broadly flat and mix shifts across products; margins were influenced by a short-term inventory advantage after ammonia supply disruption and subsequent large raw material price increases that management expects to be transient. Raw material volatility and ammonia sourcing were the headline operational issues in March, with ammonia prices reportedly rising from around INR50/kg to over INR100/kg and contracts shifting to short‑term sourcing; the company has maintained operations at roughly 60–85% utilization, been able to pass much of the cost onto customers, and flagged INR80–90 crore of near‑term capex mainly to complete existing projects. Market positioning is skewed towards regulated end‑markets: roughly 50–60% of sales go to pharma, with another 15–20% to agrochemicals, giving resilient demand orientation; competitive dynamics are improving as Chinese aggressiveness eases and antidumping measures have taken effect, but domestic new entrants such as Aarti and capacity additions by peers like Balaji create medium‑term pricing pressure in specific product chains. R&D and product pipeline remain an explicit strategic element: Alkyl runs over a dozen development projects in Pune, selectively commercializes only when engineered and validated, and retains a conservative capital deployment stance until product economics and market volatility stabilise; the company also operates multiple commissioned solar plants as part of its operational sustainability footprint.

Over the past 52 weeks, Alkyl Amines Chemicals Ltd has traded between a low of ₹1,212.35 and a high of ₹2,115.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Alkyl Amines Chemicals Ltd has a market capitalization of approximately 8,361.46. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Alkyl Amines Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 41.55 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 8,361.46 Cr, Alkyl Amines Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Alkyl Amines Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Alkyl Amines Chemicals Ltd is 41.55. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The stock rose 11.44% to Rs 1,786.55 amid strong buying, higher volume (84,431 shares), and improved sentiment in specialty chemical stocks, reversing a four-day losing streak.